Vault-13

Knott David M

Syosset, NY · CIK 808722 · 13F filing filed 2021-08-13

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$276.1m reported value +18.1% vs Q1 2021
146positions
46.8%in top 10
36 new 25 added 11 reduced 19 sold out vs Q1 2021

Options: 0 call positions (— notional), 1 put positions ($5.3m notional) – listed below, not included above.

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CALUMET SPECIALTY PRODS PART UT LTD PARTNER CLMT CLMT 3,153,300 $21.7m7.85% 7.85% AddedShares held: Q3 2020 2.0m, Q4 2020 2.6m, Q1 2021 2.8m, Q2 2021 3.2m +308.3k +308,300 10.8%
2 APOLLO GLOBAL MGMT INC COM CL A APO APO 300,000 $18.7m6.76% 6.76% UnchangedShares held: Q3 2020 300.0k, Q4 2020 300.0k, Q1 2021 300.0k, Q2 2021 300.0k
3 FORTRESS TRANS INFRST INVS L COM REP LTD LIAB FTAI FTAI 497,700 $16.7m6.05% 6.05% ReducedShares held: Q3 2020 700.0k, Q4 2020 700.0k, Q1 2021 500.0k, Q2 2021 497.7k -2.3k -2,300 -0.5%
4 COLISEUM ACQUISITION CORP UNIT 04/02/2028 UNIT 04/02/2028 1,485,000 $14.7m5.31% 5.31% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.5m
5 ALPHABET INC CAP STK CL C GOOG GOOG 5,600 $14.0m5.08% 5.08% UnchangedShares held: Q3 2020 5.6k, Q4 2020 5.6k, Q1 2021 5.6k, Q2 2021 5.6k
6 UPLAND SOFTWARE INC COM COM 300,000 $12.4m4.47% 4.47% UnchangedShares held: Q3 2020 406.5k, Q4 2020 406.5k, Q1 2021 300.0k, Q2 2021 300.0k
7 LIGAND PHARMACEUTICALS INC COM NEW LGND LGND 75,000 $9.8m3.56% 3.56% UnchangedShares held: Q3 2020 248.0k, Q4 2020 248.0k, Q1 2021 75.0k, Q2 2021 75.0k
8 FS KKR CAP CORP COM FSK FSK 395,175 $8.5m3.08% 3.08% UnchangedShares held: Q3 2020 0, Q4 2020 395.2k, Q1 2021 395.2k, Q2 2021 395.2k
9 MIDWEST HLDG INC COM NEW MDWT MDWT 165,000 $6.5m2.34% 2.34% AddedShares held: Q3 2020 83.3k, Q4 2020 143.6k, Q1 2021 150.0k, Q2 2021 165.0k +15.0k +15,000 10.0%
10 PERSHING SQUARE TONTINE HLDG COM CL A PSTH PSTH 275,000 $6.3m2.27% 2.27% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 275.0k
11 KKR & CO INC COM KKR KKR 100,000 $5.9m2.15% 2.15% UnchangedShares held: Q3 2020 100.0k, Q4 2020 100.0k, Q1 2021 100.0k, Q2 2021 100.0k
12 AFRICAN GOLD ACQUISITION COR *W EXP 03/31/202 *W EXP 03/31/202 463,500 $5.3m1.93% 1.93% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 463.5k
13 B RILEY PRINCIPAL 150 MERGER COM CL A COM CL A 526,963 $5.2m1.89% 1.89% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 527.0k
14 DANIMER SCIENTIFIC INC COM CL A COM CL A 200,000 $5.0m1.81% 1.81% UnchangedShares held: Q3 2020 0, Q4 2020 500.0k, Q1 2021 200.0k, Q2 2021 200.0k
15 TWELVE SEAS INVESTMENT CO II COM CL A COM CL A 515,000 $5.0m1.80% 1.80% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 515.0k
16 GLASS HOUSES ACQUISITION COR CLASS A COM CLASS A COM 500,000 $4.8m1.74% 1.74% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 500.0k
17 PFIZER INC COM PFE PFE 119,900 $4.7m1.70% 1.70% UnchangedShares held: Q3 2020 131.9k, Q4 2020 119.9k, Q1 2021 119.9k, Q2 2021 119.9k
18 KENNEDY-WILSON HOLDINGS INC COM KW KW 210,000 $4.2m1.51% 1.51% UnchangedShares held: Q3 2020 210.0k, Q4 2020 210.0k, Q1 2021 210.0k, Q2 2021 210.0k
19 EASTERN BANKSHARES INC COM EBC EBC 200,000 $4.1m1.49% 1.49% UnchangedShares held: Q3 2020 0, Q4 2020 200.0k, Q1 2021 200.0k, Q2 2021 200.0k
20 LIVE OAK MOBILITY ACQUISI CO COM CL A COM CL A 360,152 $3.5m1.28% 1.28% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 360.2k
21 REGENERON PHARMACEUTICALS COM REGN REGN 6,000 $3.4m1.21% 1.21% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 6.0k
22 KAIROS ACQUISITION CORP CL A SHS CL A SHS 345,463 $3.4m1.21% 1.21% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 261.4k, Q2 2021 345.5k +84.1k +84,089 32.2%
23 KADMON HLDGS INC COM KDMN KDMN 838,190 $3.2m1.17% 1.17% AddedShares held: Q3 2020 612.0k, Q4 2020 702.0k, Q1 2021 762.0k, Q2 2021 838.2k +76.2k +76,190 10.0%
24 CONSTELLATION PHARMCETICLS I COM CNST CNST 91,909 $3.1m1.13% 1.13% AddedShares held: Q3 2020 0, Q4 2020 33.0k, Q1 2021 85.9k, Q2 2021 91.9k +6.0k +6,000 7.0%
25 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 32,000 $3.0m1.09% 1.09% ReducedShares held: Q3 2020 37.5k, Q4 2020 42.6k, Q1 2021 40.6k, Q2 2021 32.0k -8.6k -8,614 -21.2%
26 BRISTOL-MYERS SQUIBB CO COM BMY BMY 43,409 $2.9m1.05% 1.05% ReducedShares held: Q3 2020 46.4k, Q4 2020 52.4k, Q1 2021 51.4k, Q2 2021 43.4k -8.0k -8,000 -15.6%
27 GLASS HOUSES ACQUISITION COR *W EXP 03/25/202 *W EXP 03/25/202 250,000 $2.9m1.04% 1.04% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 250.0k
28 JPMORGAN CHASE & CO COM JPM JPM 18,170 $2.8m1.02% 1.02% AddedShares held: Q3 2020 23.1k, Q4 2020 20.0k, Q1 2021 15.5k, Q2 2021 18.2k +2.7k +2,700 17.4%
29 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 15,300 $2.7m0.99% 0.99% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 14.5k, Q2 2021 15.3k +800 +800 5.5%
30 XENON PHARMACEUTICALS INC COM XENE XENE 140,551 $2.6m0.95% 0.95% ReducedShares held: Q3 2020 177.0k, Q4 2020 200.0k, Q1 2021 144.1k, Q2 2021 140.6k -3.5k -3,550 -2.5%
31 INTERNATIONAL GAME TECHNOLOG SHS USD BRSL BRSL 107,500 $2.6m0.93% 0.93% UnchangedShares held: Q3 2020 107.5k, Q4 2020 107.5k, Q1 2021 107.5k, Q2 2021 107.5k
32 EIGER BIOPHARMACEUTICALS INC COM CLDN CLDN 286,554 $2.4m0.88% 0.88% AddedShares held: Q3 2020 275.3k, Q4 2020 295.0k, Q1 2021 276.5k, Q2 2021 286.6k +10.0k +10,019 3.6%
33 ALLIANCEBERNSTEIN HLDG L P UNIT LTD PARTN AB AB 50,500 $2.4m0.85% 0.85% UnchangedShares held: Q3 2020 50.5k, Q4 2020 50.5k, Q1 2021 50.5k, Q2 2021 50.5k
34 ZOGENIX INC COM NEW ZGNX ZGNX 124,688 $2.2m0.78% 0.78% AddedShares held: Q3 2020 112.7k, Q4 2020 112.7k, Q1 2021 117.7k, Q2 2021 124.7k +7.0k +7,000 6.0%
35 AURINIA PHARMACEUTICALS INC COM AUPH AUPH 164,840 $2.1m0.77% 0.77% AddedShares held: Q3 2020 134.6k, Q4 2020 177.5k, Q1 2021 154.8k, Q2 2021 164.8k +10.0k +10,000 6.5%
36 HORIZON ACQUISITION CORPORAT SHS CL A SHS CL A 210,100 $2.1m0.76% 0.76% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 210.1k
37 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 304,922 $2.1m0.74% 0.74% AddedShares held: Q3 2020 0, Q4 2020 86.9k, Q1 2021 272.8k, Q2 2021 304.9k +32.1k +32,077 11.8%
38 TWELVE SEAS INVESTMENT CO II *W EXP 03/02/202 *W EXP 03/02/202 171,666 $2.0m0.72% 0.72% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 171.7k
39 TG THERAPEUTICS INC COM TGTX TGTX 50,373 $2.0m0.71% 0.71% ReducedShares held: Q3 2020 50.8k, Q4 2020 50.8k, Q1 2021 52.0k, Q2 2021 50.4k -1.6k -1,600 -3.1%
40 TASTEMAKER ACQUISITION CORP COM CL A COM CL A 200,000 $1.9m0.70% 0.70% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 200.0k, Q2 2021 200.0k
41 Medicus Science Acquisition, Corp. COMMON MS 0 09.22.23 N2U8 MS 0 09.22.23 N2U8 200,000 $1.9m0.70% 0.70% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 200.0k
42 TRILLIUM THERAPEUTICS INC COM NEW TR TR 198,699 $1.9m0.70% 0.70% UnchangedShares held: Q3 2020 176.2k, Q4 2020 174.7k, Q1 2021 198.7k, Q2 2021 198.7k
43 KAIROS ACQUISITION CORP *W EXP 11/30/202 *W EXP 11/30/202 146,528 $1.7m0.61% 0.61% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 130.7k, Q2 2021 146.5k +15.8k +15,841 12.1%
44 ASLAN PHARMACEUTICALS LTD ADS ADS 478,186 $1.6m0.57% 0.57% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 437.4k, Q2 2021 478.2k +40.8k +40,774 9.3%
45 MARINUS PHARMACEUTICALS INC COM NEW MRNS MRNS 81,166 $1.5m0.53% 0.53% AddedShares held: Q3 2020 0, Q4 2020 25.0k, Q1 2021 60.3k, Q2 2021 81.2k +20.9k +20,900 34.7%
46 UNIQURE NV SHS QURE QURE 46,766 $1.4m0.52% 0.52% AddedShares held: Q3 2020 31.0k, Q4 2020 35.0k, Q1 2021 41.8k, Q2 2021 46.8k +5.0k +5,000 12.0%
47 COHERUS BIOSCIENCES INC COM CHRS CHRS 99,655 $1.4m0.50% 0.50% UnchangedShares held: Q3 2020 99.5k, Q4 2020 101.7k, Q1 2021 99.7k, Q2 2021 99.7k
48 QUOTIENT TECHNOLOGY INC COM QUOT QUOT 125,000 $1.4m0.49% 0.49% AddedShares held: Q3 2020 0, Q4 2020 50.0k, Q1 2021 50.0k, Q2 2021 125.0k +75.0k +75,000 150.0%
49 INSPIRED ENTMT INC COM INSE INSE 100,000 $1.3m0.46% 0.46% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 100.0k
50 VIKING THERAPEUTICS INC COM VKTX VKTX 208,102 $1.2m0.45% 0.45% UnchangedShares held: Q3 2020 218.1k, Q4 2020 218.1k, Q1 2021 208.1k, Q2 2021 208.1k
51 TASTEMAKER ACQUISITION CORP *W EXP 01/07/202 *W EXP 01/07/202 100,000 $1.1m0.42% 0.42% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 100.0k, Q2 2021 100.0k
52 GILEAD SCIENCES INC COM GILD GILD 15,481 $1.1m0.39% 0.39% ReducedShares held: Q3 2020 11.0k, Q4 2020 64.8k, Q1 2021 50.9k, Q2 2021 15.5k -35.5k -35,461 -69.6%
53 IMMUNOVANT INC COM IMVT IMVT 97,294 $1.0m0.37% 0.37% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 34.1k, Q2 2021 97.3k +63.2k +63,194 185.3%
54 JOHNSON & JOHNSON COM JNJ JNJ 6,080 $1.0m0.36% 0.36% UnchangedShares held: Q3 2020 7.3k, Q4 2020 6.1k, Q1 2021 6.1k, Q2 2021 6.1k
55 MONDELEZ INTL INC CL A MDLZ MDLZ 15,900 $994.0k0.36% 0.36% UnchangedShares held: Q3 2020 15.9k, Q4 2020 15.9k, Q1 2021 15.9k, Q2 2021 15.9k
56 VERIZON COMMUNICATIONS INC COM VZ VZ 17,711 $992.0k0.36% 0.36% UnchangedShares held: Q3 2020 18.3k, Q4 2020 18.3k, Q1 2021 17.7k, Q2 2021 17.7k
57 ROTH CH ACQUISITION III CO COM COM 100,000 $987.0k0.36% 0.36% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 100.0k
58 RYMAN HOSPITALITY PPTYS INC COM RHP RHP 12,400 $980.0k0.35% 0.35% UnchangedShares held: Q3 2020 12.4k, Q4 2020 12.4k, Q1 2021 12.4k, Q2 2021 12.4k
59 CAPITOL INVESTMENT CORP V *W EXP 99/99/999 *W EXP 99/99/999 83,333 $958.0k0.35% 0.35% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 83.3k, Q2 2021 83.3k
60 DUPONT DE NEMOURS INC COM DWDP DWDP 12,118 $938.0k0.34% 0.34% UnchangedShares held: Q3 2020 12.1k, Q4 2020 12.1k, Q1 2021 12.1k, Q2 2021 12.1k
61 ABBVIE INC COM ABBV ABBV 8,000 $901.0k0.33% 0.33% ReducedShares held: Q3 2020 37.8k, Q4 2020 32.8k, Q1 2021 24.8k, Q2 2021 8.0k -16.8k -16,769 -67.7%
62 CIDARA THERAPEUTICS INC COM COM 415,308 $839.0k0.30% 0.30% UnchangedShares held: Q3 2020 407.1k, Q4 2020 415.3k, Q1 2021 415.3k, Q2 2021 415.3k
63 LIVE OAK MOBILITY ACQUISI CO *W EXP 03/04/202 *W EXP 03/04/202 72,030 $828.0k0.30% 0.30% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 72.0k
64 CANADIAN NAT RES LTD COM CNQ CNQ 22,285 $808.0k0.29% 0.29% UnchangedShares held: Q3 2020 32.0k, Q4 2020 22.3k, Q1 2021 22.3k, Q2 2021 22.3k
65 KIMBERLY-CLARK CORP COM KMB KMB 6,000 $803.0k0.29% 0.29% UnchangedShares held: Q3 2020 6.0k, Q4 2020 6.0k, Q1 2021 6.0k, Q2 2021 6.0k
66 COLOMBIER ACQUISITION CORP UNIT 99/99/9999 UNIT 99/99/9999 80,000 $794.0k0.29% 0.29% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 80.0k
67 DOW INC COM DOW DOW 12,118 $767.0k0.28% 0.28% UnchangedShares held: Q3 2020 12.1k, Q4 2020 12.1k, Q1 2021 12.1k, Q2 2021 12.1k
68 COCA COLA CO COM KO KO 13,400 $725.0k0.26% 0.26% UnchangedShares held: Q3 2020 13.4k, Q4 2020 13.4k, Q1 2021 13.4k, Q2 2021 13.4k
69 B RILEY PRINCIPAL 150 MERGER *W EXP 03/01/202 *W EXP 03/01/202 58,986 $678.0k0.25% 0.25% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 59.0k
70 BUTTERFLY NETWORK INC COM CL A BFLY BFLY 45,760 $663.0k0.24% 0.24% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 18.4k, Q2 2021 45.8k +27.4k +27,380 149.0%
71 AFRICAN GOLD ACQUISITION COR SHS CL A SHS CL A 68,000 $657.0k0.24% 0.24% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 68.0k
72 INNOVIVA INC COM INVA INVA 47,798 $641.0k0.23% 0.23% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 47.8k
73 INTERNATIONAL BUSINESS MACHS COM IBM IBM 4,284 $628.0k0.23% 0.23% UnchangedShares held: Q3 2020 4.3k, Q4 2020 4.3k, Q1 2021 4.3k, Q2 2021 4.3k
74 LONGVIEW ACQUISITION CORP II COM CL A LGV LGV 63,900 $626.0k0.23% 0.23% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 63.9k
75 AT&T INC COM T T 20,050 $577.0k0.21% 0.21% UnchangedShares held: Q3 2020 22.1k, Q4 2020 22.1k, Q1 2021 20.1k, Q2 2021 20.1k
76 CORTEVA INC COM CTVA CTVA 12,033 $534.0k0.19% 0.19% UnchangedShares held: Q3 2020 12.5k, Q4 2020 12.5k, Q1 2021 12.0k, Q2 2021 12.0k
77 MACQUARIE INFRASTRUCTURE COR COM COM 13,150 $503.0k0.18% 0.18% UnchangedShares held: Q3 2020 13.2k, Q4 2020 13.2k, Q1 2021 13.2k, Q2 2021 13.2k
78 WP CAREY INC COM WPC WPC 6,000 $448.0k0.16% 0.16% UnchangedShares held: Q3 2020 6.0k, Q4 2020 6.0k, Q1 2021 6.0k, Q2 2021 6.0k
79 UP FINTECH HLDG LTD SPONSORED ADS TIGR TIGR 13,736 $398.0k0.14% 0.14% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 13.7k, Q2 2021 13.7k
80 MICROSOFT CORP COM MSFT MSFT 1,400 $379.0k0.14% 0.14% UnchangedShares held: Q3 2020 1.4k, Q4 2020 1.4k, Q1 2021 1.4k, Q2 2021 1.4k
81 CONAGRA BRANDS INC COM CAG CAG 10,000 $364.0k0.13% 0.13% UnchangedShares held: Q3 2020 10.0k, Q4 2020 10.0k, Q1 2021 10.0k, Q2 2021 10.0k
82 GLOBUS MED INC CL A GMED GMED 4,631 $359.0k0.13% 0.13% UnchangedShares held: Q3 2020 2.9k, Q4 2020 4.6k, Q1 2021 4.6k, Q2 2021 4.6k
83 PROTARA THERAPEUTICS INC COM STK TARA TARA 36,164 $352.0k0.13% 0.13% AddedShares held: Q3 2020 7.9k, Q4 2020 14.4k, Q1 2021 14.4k, Q2 2021 36.2k +21.8k +21,795 151.7%
84 ALIMERA SCIENCES INC COM NEW ALIM ALIM 38,226 $348.0k0.13% 0.13% ReducedShares held: Q3 2020 0, Q4 2020 80.2k, Q1 2021 58.1k, Q2 2021 38.2k -19.9k -19,882 -34.2%
85 IBERE PHARMACEUTICALS SHS CL A SHS CL A 36,000 $348.0k0.13% 0.13% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 36.0k
86 META PLATFORMS INC CL A META META 990 $344.0k0.12% 0.12% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 990, Q2 2021 990
87 CRISPR THERAPEUTICS AG NAMEN AKT CRSP CRSP 2,000 $324.0k0.12% 0.12% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 2.0k
88 JUMIA TECHNOLOGIES AG SPONSORED ADS JMIA JMIA 9,800 $297.0k0.11% 0.11% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 5.7k, Q2 2021 9.8k +4.1k +4,100 71.9%
89 POSEIDA THERAPEUTICS INC COM PSTX PSTX 29,566 $296.0k0.11% 0.11% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 29.6k, Q2 2021 29.6k
90 APPLE INC COM AAPL AAPL 2,100 $288.0k0.10% 0.10% UnchangedShares held: Q3 2020 4.2k, Q4 2020 2.1k, Q1 2021 2.1k, Q2 2021 2.1k
91 ROTH CH ACQUISITION III CO *W EXP 02/26/202 *W EXP 02/26/202 25,000 $288.0k0.10% 0.10% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 25.0k
92 MEDICUS SCIENCES ACQUISITION *W EXP 02/12/202 *W EXP 02/12/202 22,222 $256.0k0.09% 0.09% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 22.2k
93 FS BANCORP INC COM FSBW FSBW 3,577 $255.0k0.09% 0.09% UnchangedShares held: Q3 2020 3.6k, Q4 2020 3.6k, Q1 2021 3.6k, Q2 2021 3.6k
94 WARRIOR TECHNOLOGIES ACQUI C COM CL A COM CL A 25,000 $242.0k0.09% 0.09% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 25.0k
95 PERRIGO CO PLC SHS PRGO PRGO 4,915 $225.0k0.08% 0.08% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 4.9k
96 SIO GENE THERAPIES INC COMMON AXON AXON 80,000 $218.0k0.08% 0.08% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 70.0k, Q2 2021 80.0k +10.0k +10,000 14.3%
97 IBERE PHARMACEUTICALS *W EXP 03/01/202 *W EXP 03/01/202 18,000 $207.0k0.07% 0.07% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 18.0k
98 RELMADA THERAPEUTICS INC COM RLMD RLMD 6,000 $192.0k0.07% 0.07% AddedShares held: Q3 2020 3.0k, Q4 2020 3.0k, Q1 2021 3.0k, Q2 2021 6.0k +3.0k +3,000 100.0%
99 SEELOS THERAPEUTICS INC COM COM 72,367 $191.0k0.07% 0.07% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 72.4k, Q2 2021 72.4k
100 ALX Oncology Holdings Inc COMMON COMMON 3,200 $175.0k0.06% 0.06% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 3.2k, Q2 2021 3.2k

Sold out since Q1 2021

SecurityTickerShares held beforeValue then
AFRICAN GOLD ACQUISITION COR 618,000 $6.1m618.0k shares
TWELVE SEAS INVESTMENT CO II 515,000 $5.1m515.0k shares
GLASS HOUSES ACQUISITION COR 500,000 $5.0m500.0k shares
LIVE OAK MOBILITY ACQUISI CO 360,152 $3.6m360.2k shares
CAPITOL INVESTMENT CORP V 250,000 $2.5m250.0k shares
HORIZON ACQUISITION CORP HZAC HZAC 210,100 $2.1m210.1k shares
MEDICUS SCIENCES ACQUISITION 200,000 $2.0m200.0k shares
B RILEY PRINCIPAL 150 MERGER 175,963 $1.8m176.0k shares
ROTH CH ACQUISITION III CO 100,000 $1.0m100.0k shares
LONGVIEW ACQUISITION CORP II 63,900 $642.0k63.9k shares
FULL HSE RESORTS INC FLL FLL 50,000 $426.0k50.0k shares
IBERE PHARMACEUTICALS 36,000 $355.0k36.0k shares
BIOCRYST PHARMACEUTICALS INC BCRX BCRX 30,703 $312.0k30.7k shares
WARRIOR TECHNOLOGIES ACQUI C 25,000 $248.0k25.0k shares
MILLENDO THERAPEUTICS INC 137,900 $165.0k137.9k shares
ISHARES TR IBB IBB 1,000 $151.0k1.0k shares
KAIROS ACQUISITION CORP 14,500 $145.0k14.5k shares
INDEPENDENCE HOLDINGS CORP 9,500 $95.0k9.5k shares
COLONY CAP INC NEW 12,466 $81.0k12.5k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SUPPORT COM INC SPRT · Put SPRTPut 1,361,900 $5.3m1.4m shares New